Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel S Kapp

Showing results (61-70 of 144) with videos related to

Pageof 15
Sort By:
Gynecologic Oncology|August 15, 2009
Adjuvant radiation therapy in stage III node-positive uterine cancerSeraina Schmid, I-Chow Hsu, Jessica M Hu, et al.
The Oncologist|March 7, 2014
Applications for oncologic drugs: a descriptive analysis of the oncologic drugs advisory committee reviewsJohn K Chan, Tuyen K Kiet, Bradley J Monk, et al.
Cancer|September 16, 2006
Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patientsJohn K Chan, Michael K Cheung, Warner K Huh, et al.
Preventing Chronic Disease|March 30, 2023
Trends in Incidence of Cancers Associated With Obesity and Other Modifiable Risk Factors Among Women, 2001-2018Katherine R Cotangco, Cheng-I Liao, Cortney M Eakin, et al.
International Journal of Radiation Oncology, Biology, Physics|August 17, 2002
Evaluation of the effect of routine packed red blood cell transfusion in anemic cervix cancer patients treated with radical radiotherapyKarin S Kapp, Johann Poschauko, Edith Geyer, et al.
JAMA Network Open|March 16, 2022
Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017Cheng-I Liao, Alex Andrea Francoeur, Daniel S Kapp, et al.
Gynecologic Oncology|December 1, 2009
The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group studyJohn K Chan, Chunqiao Tian, Gini F Fleming, et al.
Journal of Surgical Oncology|June 20, 2008
The influence of conservative surgical practices for malignant ovarian germ cell tumorsJohn K Chan, Krishnansu S Tewari, Sarah Waller, et al.
Gynecologic Oncology|October 24, 2007
Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancerJohn K Chan, Daniel S Kapp, Jacob Y Shin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2017
Second Neoplasms in Patients With Hodgkin's Disease Following Combined Modality Therapy-The Yale ExperienceAlan J Koletsky, Joseph R Bertino, Leonard R Farber, et al.
Pageof 15

Showing results (61-70 of 144) with videos related to

Sort By:
Pageof 15
Gynecologic Oncology|August 15, 2009
Adjuvant radiation therapy in stage III node-positive uterine cancerSeraina Schmid, I-Chow Hsu, Jessica M Hu, et al.
The Oncologist|March 7, 2014
Applications for oncologic drugs: a descriptive analysis of the oncologic drugs advisory committee reviewsJohn K Chan, Tuyen K Kiet, Bradley J Monk, et al.
Cancer|September 16, 2006
Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patientsJohn K Chan, Michael K Cheung, Warner K Huh, et al.
Preventing Chronic Disease|March 30, 2023
Trends in Incidence of Cancers Associated With Obesity and Other Modifiable Risk Factors Among Women, 2001-2018Katherine R Cotangco, Cheng-I Liao, Cortney M Eakin, et al.
International Journal of Radiation Oncology, Biology, Physics|August 17, 2002
Evaluation of the effect of routine packed red blood cell transfusion in anemic cervix cancer patients treated with radical radiotherapyKarin S Kapp, Johann Poschauko, Edith Geyer, et al.
JAMA Network Open|March 16, 2022
Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017Cheng-I Liao, Alex Andrea Francoeur, Daniel S Kapp, et al.
Gynecologic Oncology|December 1, 2009
The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group studyJohn K Chan, Chunqiao Tian, Gini F Fleming, et al.
Journal of Surgical Oncology|June 20, 2008
The influence of conservative surgical practices for malignant ovarian germ cell tumorsJohn K Chan, Krishnansu S Tewari, Sarah Waller, et al.
Gynecologic Oncology|October 24, 2007
Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancerJohn K Chan, Daniel S Kapp, Jacob Y Shin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2017
Second Neoplasms in Patients With Hodgkin's Disease Following Combined Modality Therapy-The Yale ExperienceAlan J Koletsky, Joseph R Bertino, Leonard R Farber, et al.
Pageof 15